Definition
No sperm are seen in the ejaculate or in the post-centrifugation pellet.
Azoospermia means that no sperm cells are found in a semen sample, including after centrifugation and pellet examination. Obstructive causes should be distinguished from impaired sperm production.

In some men, sperm are produced in the testes but cannot reach the ejaculate because of obstruction; in others, sperm production may persist only in small focal areas.
No sperm are seen in the ejaculate or in the post-centrifugation pellet.
Azoospermia is classified as obstructive when sperm transport is blocked and non-obstructive when sperm production is severely impaired.
Repeat semen analysis, clinical examination, hormone tests, genetic assessment and ultrasound when indicated are used in diagnosis.
Depending on the cause, reconstruction, epididymal or testicular sperm retrieval and ICSI may be considered.
Azoospermia does not mean absence of semen; it means that no sperm cells are found in the semen sample.
Diagnosis is generally confirmed in at least two appropriately collected samples with detailed post-centrifugation examination. The next step is to determine whether the cause is obstruction or impaired sperm production.
In obstructive azoospermia, sperm production may be preserved in the testes, but sperm cannot reach the ejaculate because of causes such as congenital absence of the vas deferens, infection, surgery or vasectomy.
In non-obstructive azoospermia, sperm production is severely impaired. Small focal areas of sperm production may nevertheless remain, and Micro-TESE may be considered to search for sperm in selected patients.
Low semen volume, FSH and testosterone levels, testicular volume, examination of the vas deferens and genetic findings can help with classification.

In both conditions no sperm are found in the ejaculate, but testicular sperm production and treatment options differ.
Sperm production is often preserved, but sperm transport through the reproductive tract is blocked.
Sperm production in the testes is markedly reduced and may persist only in focal areas.
Finding a very small number of sperm after centrifugation is cryptozoospermia rather than azoospermia and may change treatment planning.
Any man in whom no sperm are seen on an initial semen analysis should have a structured assessment.
The diagnosis should be confirmed and sample-related error excluded.
Ejaculatory dysfunction, congenital absence of the vas deferens or ejaculatory-duct obstruction may be investigated.
These findings can increase suspicion of impaired sperm production.
Assessment for possible obstruction may be appropriate.
History of gonadotoxic treatment or testicular surgery is relevant.
Specific counselling is required for conditions such as Klinefelter syndrome, Y-chromosome microdeletions or congenital absence of the vas deferens.
No. Surgery should not be planned before reviewing genetic findings, the likely cause, the female partner’s fertility status and the most appropriate sperm-retrieval method.
The aim is not only to look for sperm, but also to identify the cause and relevant associated health risks.
The post-centrifugation pellet is examined microscopically.
These provide information about sperm production and the hormonal axis.
Testicular volume, epididymis and vas deferens are assessed.
Chromosomal analysis may be indicated in azoospermia.
Results can inform counselling about the likelihood of sperm retrieval and possible transmission to male offspring.
These may be considered when obstruction, absent vas deferens or another anatomical cause is suspected.
Treatment is based on the diagnostic category and the couple’s reproductive goals.
A repeat semen analysis and pellet examination are performed.
Medical history, examination, hormone levels and semen volume help with the initial distinction.
Relevant tests and genetic counselling are completed when indicated.
Age and ovarian reserve influence the timing of surgical sperm retrieval and IVF.
Reconstruction or sperm retrieval from the epididymis/testis may be considered.
In selected patients, Micro-TESE is used to search for focal areas of sperm production.
Tissue is examined promptly and systematically in the embryology laboratory.
Retrieved sperm may be used fresh or suitable sperm may be cryopreserved.
Diagnostic and genetic testing may take several weeks; the surgical procedure is scheduled separately.
Two separate samples are generally required.
Results may be available relatively quickly.
Turnaround time may be longer depending on the laboratory.
This can often be performed on the same day.
Timing is coordinated with the female partner’s IVF schedule.
Laboratory assessment is performed on the day of the procedure.
The diagnostic consultation itself may be brief. TESE or Micro-TESE often requires the procedure day and short follow-up, although coordinated IVF may change the required stay.
No single hormone level or examination finding can reliably predict sperm retrieval.
Sperm retrieval is generally more likely in obstructive azoospermia.
Whether focal sperm production is present in the testis is important.
Findings such as complete AZFa/AZFb deletions can determine whether sperm-retrieval surgery is appropriate.
Previous biopsy or testicular damage can influence surgical planning.
Microsurgical technique and the laboratory’s experience with immediate tissue examination are important.
Embryo and pregnancy outcomes after sperm retrieval also depend on oocyte age and quality.
Finding sperm, achieving fertilisation and achieving a live birth are different outcomes. Even when sperm are retrieved, ICSI, embryo development and pregnancy each have separate uncertainties.
Costs vary according to diagnostic tests, the surgical method and the IVF laboratory plan.
Confirmation including post-centrifugation pellet examination.
FSH, LH, testosterone and selected additional tests.
Karyotype, Y-chromosome microdeletion testing and CFTR assessment when indicated.
Scrotal or transrectal ultrasound.
TESE, Micro-TESE, PESA or MESA.
Use of retrieved sperm, cryopreservation and storage.
Share your semen analyses, hormone and genetic results so the appropriate diagnostic and surgical steps can be reviewed.
Surgical tissue should be handled through an uninterrupted identity and documentation chain between the operating theatre and embryology laboratory.
A detailed post-centrifugation search is performed when confirming azoospermia.
Tissue from each sampled testicular area is labelled separately and transferred to the laboratory.
Seminiferous tubules are processed carefully and examined microscopically for sperm.
Viability of immotile sperm may be assessed using appropriate laboratory methods when needed.
Suitable retrieved sperm may be stored in small, traceable aliquots.
The sperm and oocyte sources are verified through the laboratory identity system.

Urology/andrology, the IVF physician and embryology laboratory coordinate timing.

Coordinates the female partner’s IVF and oocyte-retrieval timing with surgical sperm retrieval.
View profile →
Coordinates diagnosis, genetic counselling and multidisciplinary treatment decisions.
View profile →
Manages laboratory sperm search in surgical tissue, viability assessment, ICSI and cryopreservation.
View profile →Classification of azoospermia and surgical sperm retrieval should be planned by an appropriate urology/andrology specialist.
Realistic expectations and genetic counselling are important parts of treatment.
No sperm may be found during TESE or Micro-TESE.
Pain, bleeding, infection, haematoma and temporary changes in hormone levels can occur.
Some genetic causes may be transmitted to male offspring.
Surgical sperm retrieval is generally not recommended with complete AZFa/AZFb deletions.
The number of retrieved sperm may be insufficient for freezing or repeated future use.
Finding sperm does not guarantee embryo development, pregnancy or live birth.
Key information about diagnosis, genetic assessment and sperm-retrieval options.
It means that no sperm cells are found in the semen sample, including after centrifugation and pellet examination.
It is generally confirmed with at least two appropriately performed semen analyses.
No. In azoospermia, semen may be ejaculated but no sperm are present in it.
Depending on the cause, surgical sperm retrieval followed by ICSI may make treatment possible, but success cannot be guaranteed.
Sperm are produced but cannot reach the ejaculate because of obstruction or absence of part of the reproductive tract.
It is a condition in which sperm production within the testes is severely impaired.
Karyotype and Y-chromosome microdeletion testing are commonly considered; CFTR testing may be appropriate when congenital absence of the vas deferens is suspected.
The method depends on whether obstruction or impaired production is present; Micro-TESE is commonly preferred in selected cases of non-obstructive azoospermia.
High FSH may be associated with a lower retrieval probability but cannot predict the result with certainty on its own.
It may be discussed in selected cases after reviewing previous surgical findings and genetic results.
No. The cause and possible surgical sperm-retrieval options should be assessed first; donor sperm is a separate treatment option.
Diagnostic tests may be completed in advance; the surgical procedure and short follow-up can often be planned within a brief stay.